A New Multimodal Treatment Approach for Children With Spastic Diplegic Cerebral Palsy
NCT ID: NCT05504798
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-08-01
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calf Muscle Strength and Standing Efficiency in Children With Spastic Diplegia
NCT02105649
Functional Electrical Stimulation With Core Stabilization Exercises in Children With Spastic Diplegia
NCT07110025
Effect of Electrical Stimulation With Functional Task Training on Balance and Motor Abilities in Children With Diplegia
NCT06234215
Weight Bearing Exercises With NMES on Balance and Functional Abilities In Children With Hemiplegia
NCT07069946
Role of Dynamic Movement Intervention in Children with Spastic Diplegia
NCT06270550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group (A)
will receive a selected physical therapy program.
Selected physical therapy program
Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.
Group (B)
will receive interrupted progressive serial casting in addition to a modified selected physical therapy program during casting.
Selected physical therapy program
Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.
Interrupted serial casting
Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.
Group (C)
will receive interrupted progressive serial casting and the modified selected physical therapy as group (B) in addition to neuromuscular electrical stimulation for ankle dorsiflexors and knee extensors muscles through cast windows
Selected physical therapy program
Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.
Interrupted serial casting
Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation in form of faradic current with frequency of 50 Hz, and intensity of maximum tolerable intensity to produce a visible contraction but as tolerated by the child for ankle dorsiflexors and knee extensors muscles through cast windows over the motor points of these muscles for 30 min 3 times weekly for six successive weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Selected physical therapy program
Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.
Interrupted serial casting
Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation in form of faradic current with frequency of 50 Hz, and intensity of maximum tolerable intensity to produce a visible contraction but as tolerated by the child for ankle dorsiflexors and knee extensors muscles through cast windows over the motor points of these muscles for 30 min 3 times weekly for six successive weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The children will have Level II, or III according to the Gross Motor Function Classification System.
* The children walk with equinus or jump gait patterns with spasticity of the hamstrings and hip flexors in addition to calf muscles spasticity.
* Children take their Antispastic drug use such as baclofen, diazepam or tizanidine.
* All children will be able to follow instructions.
Exclusion Criteria
* Cognitive dysfunction.
* Poor skin integrity.
* History of or recent nonunion fracture.
* Fixed contractures and deformities.
* Previous surgery (tendon lengthening).
* Received Botulinum toxin A injections in the last six months.
* Impaired circulation.
3 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasser Mamdouh Abd Elmonem Mohamed
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Physical Therapy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/003675
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.